News | Nuclear Imaging | May 10, 2016

MEDraysintell to Showcase Nuclear Imaging Reports at SNMMI 2016

Series of reports include nuclear medicine, cyclotrons, brachytherapy and proton therapy

Medraysintell, SNMMI 2016, nuclear imaging reports

May 10, 2016 — MEDraysintell announced it will display its series of market reports and directories during the Society of Nuclear Medicine and Molecular Imaging (SNMMI) congress, June 11-15, in San Diego. The reports contain over 1,800 pages of intelligence covering nuclear medicine, cyclotrons, brachytherapy and proton therapy.

Nuclear Medicine World Market Report & Directory, Edition 2015 is a 930-page report and directory describing and analyzing over 335 radiopharmaceuticals and radionuclides, and more than 160 companies and institutions active in nuclear medicine.

Cyclotrons used in Nuclear Medicine, Edition 2015 is a 350-page report providing an extensive review of all cyclotrons around the world (over 1,200) with an exhaustive profile of the 14 companies active in this market.

The global brachytherapy industry is evaluated in a new and updated MEDraysintell report and directory, providing in a 340-page document a complete description of the radionuclides and devices used in brachytherapy, and a detailed profile of 62 companies and institutions active in this field around the world.

Proton Therapy world market report, Edition 2015 is the most comprehensive evaluation of the world proton therapy industry. This report includes a complete market review and contains a detailed profile of all promoters, manufacturers or developers of proton and carbon therapy equipment.

MEDraysintell reports and directories can be customized to specific areas or modalities. Sample pages and complete table of contents are available upon request.

For more information: www.medraysintell.com

Related Content

NIH Study of Brain Energy Patterns Provides New Insights into Alcohol Effects

NIH scientists present a new method for combining measures of brain activity (left) and glucose consumption (right) to study regional specialization and to better understand the effects of alcohol on the human brain. Image courtesy of Ehsan Shokri-Kojori, Ph.D., of NIAAA.

News | Neuro Imaging | March 22, 2019
March 22, 2019 — Assessing the patterns of energy use and neuronal activity simultaneously in the human brain improve
Improving Molecular Imaging Using a Deep Learning Approach
News | Nuclear Imaging | March 21, 2019
Generating comprehensive molecular images of organs and tumors in living organisms can be performed at ultra-fast speed...
PET Scans Show Biomarkers Could Spare Some Breast Cancer Patients from Chemotherapy
News | PET Imaging | March 18, 2019
A new study positron emission tomography (PET) scans has identified a biomarker that may accurately predict which...
Researchers Create New Method for Developing Cancer Imaging Isotopes

Prototype fluidic system for zirconium-89 purification. Image taken through a hot cell window at the Department of Radiology, University of Washington. Image courtesy of Matthew O’Hara, Pacific Northwest National Laboratory

News | Radiopharmaceuticals and Tracers | March 14, 2019
A team of researchers at the University of Washington announced they developed a new automated system for producing...
Siemens Healthineers Announces First U.S. Install of Biograph Vision PET/CT
News | PET-CT | March 06, 2019
Siemens Healthineers’ new Biograph Vision positron emission tomography/computed tomography (PET/CT) system has been...
ImaginAb Enrolls First Patient in Phase II PET Agent Clinical Trial
News | Radiopharmaceuticals and Tracers | January 30, 2019
ImaginAb Inc. announced the enrollment of the first patient in the Phase II clinical trial of the company’s CD8+ T Cell...
FDA Clears United Imaging Healthcare uExplorer Total-Body Scanner
Technology | PET-CT | January 23, 2019
January 23, 2019 — United Imaging Healthcare (United Imaging) announced U.S.
MIM Software Inc. Receives FDA 510(k) Clearance for Molecular Radiotherapy Dosimetry
Technology | Nuclear Imaging | January 16, 2019
MIM Software Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for molecular radiotherapy...
Videos | SPECT-CT | December 12, 2018
This is a walk around of the new Spectrum Dynamics Veriton SPECT-CT nuclear imaging system introduced at the 2018 ...